TORONTO & DALLAS--(BUSINESS WIRE)--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, today announced that Jeremy Sobotta, Perimeter’s Chief Executive Officer, will host one-on-one investor meetings and participate in an industry panel discussion at the 34th Annual Roth Conference taking place in Dana Point, CA from March 13-15, 2022.
Panel Discussion Details
Date/Time: Monday, March 14, 2022 at 12:30 pm PT / 3:30 pm ET
Title: “Looking to Canadian Markets for Access to Public Venture Capital and Growth Investment Opportunities”
Hear from the Exchanges and top cross border counsel about current trends and recent market activity, then learn about how some of our presenting companies have leveraged the idea of Public Venture Capital to build their businesses. Panel sponsored by TMX and Dorsey & Whitney LLP.
Moderator: Brady Fletcher, President & Head of Investment Banking, ROTH Canada, ULC
Webcast: To access a live webcast of this panel discussion, please click here.
Details on company presentations and webcasts can be found on the “Investors” section of Perimeter’s website at https://ir.perimetermed.com/. When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.
About the 34th Annual Roth Conference
This year’s event will consist of one-on-one / small group meetings, analyst-selected fireside chats, thematic industry panels, and on-demand presentations by executive management from approximately 400 private and public companies in a variety of growth sectors including: Blockchain/Cryptocurrency, Business Services, Consumer / Health & Wellness, Healthcare, Resources: Oil & Gas / Meals & Mining, Technology & Media and Sustainability/ESG. To learn more and submit a registration request, visit https://ibn.fm/ROTH2022Registration.
About Perimeter Medical Imaging AI, Inc.
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation, artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” refers to the pink ribbons used during Breast Cancer Awareness Month.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.